<DOC>
	<DOCNO>NCT00347711</DOCNO>
	<brief_summary>To evaluate effect Intravitreal Bevacizumab macular edema retinal vascular occlusion .</brief_summary>
	<brief_title>Bevacizumab Retinal Vascular Occlusions</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<criteria>Vascular occlusion edema macular diagnosticated fluorescein angiography coherent optic tomography Previous surgery Uveitis Glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>